At Amryt Pharma, we look beyond the ordinary, unearthing scientific potential and delivering medicines that may have the potential to change the lives of people with rare, debilitating conditions. Through our in-depth knowledge and bold approach we combine the expertise and innovation needed to help patients and their caregivers to access new treatments quickly and responsibly.
Joe Wiley, CEO
Amryt Pharma supports the aims and objectives of advocacy groups working across rare and debilitating diseases to help patients and their families and carers.
This is an exciting time for Amryt Pharma. We are a successful, thriving global company poised to achieve unparalleled results. Our success is driven and defined by the inspiring people who embody our values and wake up every day with the goal of changing lives of people with rare and debilitating diseases.
Please find the latest annual report presentation below:
Please click the link above if you wish to be alerted about significant changes to the content of the site. If you have already subscribed you can also log-in through the link.